Lunai Bioworks Inc. Research and Development Expense
Lunai Bioworks Inc. (LNAI) reported Research and Development Expense of $15.95 thousand for the 3-month period ending 2026-03-31, per its 10-Q filed 2026-05-15.
Financial Statements › Expense Statement › Operating Expenses
us-gaap:ResearchAndDevelopmentExpense · last filed 2026-05-15
- Lunai Bioworks Inc. research and development expense for the quarter ending 2026-03-31 was $15.95K.
- Lunai Bioworks Inc. research and development expense for the quarter ending 2025-12-31 was $45.87K, a 71.52% decline year-over-year.
- Lunai Bioworks Inc. research and development expense for the quarter ending 2025-09-30 was $24.41K, a 93.74% decline year-over-year.
- Lunai Bioworks Inc. research and development expense for the quarter ending 2024-12-31 was $161.08K, a 74.04% decline year-over-year.
- Lunai Bioworks Inc. research and development expense for fiscal 2025 was $537.43K, a 80.16% decline from fiscal 2024.
- Lunai Bioworks Inc. research and development expense for fiscal 2024 was $2.71M, a 34.97% decline from fiscal 2023.
- Lunai Bioworks Inc. research and development expense for fiscal 2023 was $4.17M, a 50.25% decline from fiscal 2022.
- Lunai Bioworks Inc. research and development expense for fiscal 2022 was $8.37M, a 46.74% decline from fiscal 2021.
| Period end | Research and Development Expense 3 month | Research and Development Expense 3 month as first filed | Research and Development Expense 6 month | Research and Development Expense 6 month as first filed | Research and Development Expense 9 month | Research and Development Expense 9 month as first filed | Research and Development Expense 12 month | Research and Development Expense 12 month as first filed |
|---|---|---|---|---|---|---|---|---|
| 2026-03-31 | $15.95K 10-Q · filed 2026-05-15 | $61.82K derived: sum of 2 quarters · filed 2026-05-15 | $86.23K 10-Q · filed 2026-05-15 | |||||
| 2025-12-31 | $45.87K 10-Q · filed 2026-02-17 | $70.28K 10-Q · filed 2026-02-17 | ||||||
| 2025-09-30 | $24.41K 10-Q · filed 2025-11-14 | |||||||
| 2025-06-30 | $537.43K 10-K · filed 2025-09-29 | |||||||
| 2024-12-31 | $161.08K 10-Q · filed 2026-02-17 | $551.27K 10-Q · filed 2026-02-17 | $985.78K derived: sum of 3 quarters · filed 2026-02-17 | $2.07M derived: sum of 4 quarters · filed 2026-02-17 | ||||
| 2024-09-30 | $390.19K 10-Q · filed 2025-11-14 | $824.70K derived: sum of 2 quarters · filed 2025-11-14 | $1.91M derived: sum of 3 quarters · filed 2025-11-14 | $2.53M derived: sum of 4 quarters · filed 2025-11-14 | ||||
| 2024-06-30 | $434.51K derived: 10-K 12 month − 10-Q/A 9 month · filed 2025-09-29 | $1.52M derived: sum of 2 quarters · filed 2025-09-29 | $2.14M derived: sum of 3 quarters · filed 2025-09-29 | $2.71M 10-K · filed 2025-09-29 | ||||
| 2024-03-31 | $1.09M 10-Q/A · filed 2025-02-19 | $1.71M derived: sum of 2 quarters · filed 2025-02-19 | $2.27M 10-Q/A · filed 2025-02-19 | $3.27M derived: sum of 4 quarters · filed 2025-02-19 | ||||
| 2023-12-31 | $620.52K 10-Q · filed 2025-02-19 | $1.19M 10-Q · filed 2025-02-19 | $2.18M derived: sum of 3 quarters · filed 2025-02-19 | $2.42M derived: sum of 4 quarters · filed 2025-02-19 | ||||
| 2023-09-30 | $566.64K 10-Q/A · filed 2025-02-19 | $1.56M derived: sum of 2 quarters · filed 2025-02-19 | $1.80M derived: sum of 3 quarters · filed 2025-02-19 | $2.13M derived: sum of 4 quarters · filed 2025-02-19 | ||||
| 2023-06-30 | $994.73K derived: 10-K/A 12 month − 10-Q/A 9 month · filed 2025-02-19 | $1.23M derived: sum of 2 quarters · filed 2025-02-19 | $1.56M derived: sum of 3 quarters · filed 2025-02-19 | $4.17M 10-K/A · filed 2025-02-19 | ||||
| 2023-03-31 | $239.14K 10-Q/A · filed 2025-02-19 | $565.10K derived: sum of 2 quarters · filed 2025-02-19 | $3.17M 10-Q/A · filed 2025-02-19 | $4.94M derived: sum of 4 quarters · filed 2025-02-19 | ||||
| 2022-12-31 | $325.96K 10-Q · filed 2024-02-14 | $2.93M 10-Q · filed 2024-02-14 | $4.70M derived: sum of 3 quarters · filed 2024-02-14 | $5.91M derived: sum of 4 quarters · filed 2024-02-14 | ||||
| 2022-09-30 | $2.61M 10-Q · filed 2023-11-14 | $4.37M derived: sum of 2 quarters · filed 2023-11-14 | $5.59M derived: sum of 3 quarters · filed 2023-11-14 | $7.92M derived: sum of 4 quarters · filed 2023-11-14 | ||||
| 2022-06-30 | $1.77M derived: 10-K 12 month − 10-Q 9 month · filed 2023-10-02 | $2.98M derived: sum of 2 quarters · filed 2023-10-02 | $5.32M derived: sum of 3 quarters · filed 2023-10-02 | $8.37M 10-K · filed 2023-10-02 | ||||
| 2022-03-31 | $1.21M 10-Q · filed 2023-05-12 | $3.55M derived: sum of 2 quarters · filed 2023-05-12 | $6.61M 10-Q · filed 2023-05-12 | $18.75M derived: sum of 4 quarters · filed 2023-05-12 | ||||
| 2021-12-31 | $2.34M 10-Q · filed 2023-03-09 | $2.14M 10-Q · filed 2022-02-14 | $5.39M 10-Q · filed 2023-03-09 | $5.15M 10-Q · filed 2022-02-14 | $17.54M derived: sum of 3 quarters · filed 2023-03-09 | $18.66M derived: sum of 4 quarters · filed 2023-03-09 | ||
| 2021-09-30 | $3.06M 10-Q · filed 2023-03-07 | $3.01M 10-Q · filed 2021-11-15 | $15.20M derived: sum of 2 quarters · filed 2023-03-07 | $16.32M derived: sum of 3 quarters · filed 2023-03-07 | $17.65M derived: sum of 4 quarters · filed 2023-03-07 | |||
| 2021-06-30 | $12.15M derived: 10-K 12 month − 10-Q 9 month · filed 2023-02-27 | $13.26M derived: sum of 2 quarters · filed 2023-02-27 | $14.60M derived: sum of 3 quarters · filed 2023-02-27 | $15.72M 10-K · filed 2023-02-27 | $15.54M 10-K · filed 2021-09-24 | |||
| 2021-03-31 | $1.12M 10-Q · filed 2022-05-13 | $1.08M 10-Q · filed 2021-05-17 | $2.45M derived: sum of 2 quarters · filed 2022-05-13 | $3.57M 10-Q · filed 2022-05-13 | $3.46M 10-Q · filed 2021-05-17 | $4.81M derived: sum of 4 quarters · filed 2022-05-13 | ||
| 2020-12-31 | $1.33M 10-Q · filed 2022-02-14 | $2.38M 10-Q · filed 2022-02-14 | $3.69M derived: sum of 3 quarters · filed 2022-02-14 | $6.00M derived: sum of 4 quarters · filed 2022-02-14 | ||||
| 2020-09-30 | $1.05M 10-Q · filed 2021-11-15 | $2.36M derived: sum of 2 quarters · filed 2021-11-15 | $4.66M derived: sum of 3 quarters · filed 2021-11-15 | $5.22M derived: sum of 4 quarters · filed 2021-11-15 | ||||
| 2020-06-30 | $1.31M derived: 10-K 12 month − 10-Q 9 month · filed 2021-09-24 | $3.61M derived: sum of 2 quarters · filed 2021-09-24 | $4.17M derived: sum of 3 quarters · filed 2021-09-24 | $4.69M 10-K · filed 2021-09-24 | ||||
| 2020-03-31 | $2.31M 10-Q · filed 2021-05-17 | $2.87M derived: sum of 2 quarters · filed 2021-05-17 | $3.39M 10-Q · filed 2021-05-17 | $3.87M derived: sum of 4 quarters · filed 2021-05-17 | ||||
| 2019-12-31 | $561.47K 10-Q · filed 2021-02-16 | $1.08M 10-Q · filed 2021-02-16 | $1.57M derived: sum of 3 quarters · filed 2021-02-16 | $2.30M derived: sum of 4 quarters · filed 2021-02-16 | ||||
| 2019-09-30 | $520.19K 10-Q · filed 2020-11-12 | $1.01M derived: sum of 2 quarters · filed 2020-11-12 | $1.74M derived: sum of 3 quarters · filed 2020-11-12 | $2.52M derived: sum of 4 quarters · filed 2020-11-12 | ||||
| 2019-06-30 | $485.33K derived: 10-K 12 month − 10-Q 9 month · filed 2020-09-23 | $1.22M derived: sum of 2 quarters · filed 2020-09-23 | $2.00M derived: sum of 3 quarters · filed 2020-09-23 | $2.50M 10-K · filed 2020-09-23 | ||||
| 2019-03-31 | $730.25K 10-Q · filed 2020-05-11 | $1.52M derived: sum of 2 quarters · filed 2020-05-11 | $2.01M 10-Q · filed 2020-05-11 | $2.12M derived: sum of 4 quarters · filed 2020-05-11 | ||||
| 2018-12-31 | $788.97K 10-Q · filed 2020-02-10 | $1.28M 10-Q · filed 2020-02-10 | $1.39M derived: sum of 3 quarters · filed 2020-02-10 | $1.53M derived: sum of 4 quarters · filed 2020-02-10 | ||||
| 2018-09-30 | $493.56K 10-Q · filed 2019-11-13 | $598.98K derived: sum of 2 quarters · filed 2019-11-13 | $736.89K derived: sum of 3 quarters · filed 2019-11-13 | $956.86K derived: sum of 4 quarters · filed 2019-11-13 | ||||
| 2018-06-30 | $105.42K derived: 10-K 12 month − 10-Q 9 month · filed 2019-09-30 | $243.34K derived: sum of 2 quarters · filed 2019-09-30 | $463.31K derived: sum of 3 quarters · filed 2019-09-30 | $616.96K 10-K · filed 2019-09-30 | ||||
| 2018-03-31 | $137.92K 10-Q · filed 2019-05-16 | $357.88K derived: sum of 2 quarters · filed 2019-05-16 | $511.54K 10-Q · filed 2019-05-16 | $527.12K derived: sum of 4 quarters · filed 2019-05-16 | ||||
| 2017-12-31 | $219.97K 10-Q · filed 2019-02-13 | $373.62K 10-Q · filed 2019-02-13 | $389.20K derived: sum of 3 quarters · filed 2019-02-13 | $405.49K derived: sum of 4 quarters · filed 2019-02-13 | ||||
| 2017-09-30 | $153.65K 10-Q · filed 2018-11-14 | $169.23K derived: sum of 2 quarters · filed 2018-11-14 | $185.52K derived: sum of 3 quarters · filed 2018-11-14 | $199.31K derived: sum of 4 quarters · filed 2018-11-14 | ||||
| 2017-06-30 | $15.58K derived: 10-K 12 month − 10-Q 9 month · filed 2018-10-01 | $31.87K derived: sum of 2 quarters · filed 2018-10-01 | $45.66K derived: sum of 3 quarters · filed 2018-10-01 | $62.76K 10-K · filed 2018-10-01 | ||||
| 2017-03-31 | $16.29K 10-Q · filed 2018-05-15 | $30.08K derived: sum of 2 quarters · filed 2018-05-15 | $47.18K 10-Q · filed 2017-05-15 | $236.03K derived: sum of 4 quarters · filed 2018-05-15 | ||||
| 2016-12-31 | $13.79K 10-Q · filed 2018-02-09 | $30.89K 10-Q · filed 2018-02-09 | $219.75K derived: sum of 3 quarters · filed 2018-02-09 | $455.67K derived: sum of 4 quarters · filed 2018-02-09 | ||||
| 2016-09-30 | $17.10K 10-Q · filed 2017-11-20 | $205.96K derived: sum of 2 quarters · filed 2017-11-20 | $441.88K derived: sum of 3 quarters · filed 2017-11-20 | $719.53K derived: sum of 4 quarters · filed 2017-11-20 | ||||
| 2016-06-30 | $188.85K derived: 10-K 12 month − 10-Q 9 month · filed 2017-11-20 | $424.78K derived: sum of 2 quarters · filed 2017-11-20 | $702.43K derived: sum of 3 quarters · filed 2017-11-20 | $804.19K 10-K · filed 2017-11-20 | ||||
| 2016-03-31 | $235.93K 10-Q · filed 2017-05-15 | $513.58K derived: sum of 2 quarters · filed 2017-05-15 | $615.33K 10-Q · filed 2017-05-15 | $2.09M derived: sum of 4 quarters · filed 2017-05-15 | ||||
| 2015-12-31 | $277.65K 10-Q · filed 2017-02-14 | $379.41K 10-Q · filed 2017-02-14 | $1.85M derived: sum of 3 quarters · filed 2017-02-14 | $2.00M derived: sum of 4 quarters · filed 2017-02-14 | ||||
| 2015-09-30 | $101.76K 10-Q · filed 2016-11-14 | $1.58M derived: sum of 2 quarters · filed 2016-11-14 | $1.73M derived: sum of 3 quarters · filed 2016-11-14 | |||||
| 2015-06-30 | $1.47M derived: 10-K 6 month − 10-Q 3 month · filed 2016-09-28 | $1.63M 10-K · filed 2016-09-28 | ||||||
| 2015-03-31 | $151.81K 10-Q · filed 2016-05-13 | $151.81K 10-Q · filed 2016-05-13 | ||||||
| 2014-09-30 | $143.15K 10-Q · filed 2014-11-13 | $221.55K 10-Q · filed 2014-11-13 | ||||||
| 2013-09-30 | $0.00 10-Q · filed 2014-11-13 | $0.00 10-Q · filed 2014-11-13 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| PMV Pharmaceuticals, Inc. (PMVP) | United States | $0.071B | -0.95 |
| TENAX THERAPEUTICS, INC. (TENX) | United States | $0.071B | -7.17 |
| PLIANT THERAPEUTICS, INC. (PLRX) | United States | $0.071B | -0.76 |
| Spero Therapeutics, Inc. (SPRO) | United States | $0.073B | 17.41 |
| Cingulate Inc. (CING) | United States | $0.073B | -2.64 |
| Yarrow Bioscience, Inc. (YARW) | United States | $0.070B | |
| Aldeyra Therapeutics, Inc. (ALDX) | United States | $0.074B | -5.57 |
| Connect Biopharma Holdings Ltd (CNTB) | $0.069B | -2.17 | |
| OS Therapies Inc (OSTX) | United States | $0.076B | -2.17 |
| Verrica Pharmaceuticals Inc. (VRCA) | United States | $0.076B | -3.39 |